ScholarGate
Asistenti

Krahasoni metodat

Shqyrtoni metodat e zgjedhura krah për krah; rreshtat që ndryshojnë janë të theksuar.

Studim i Fazës IV i rregulluar sipas rrezikut×Studim Kohorte×
FushaEpidemiologjiEpidemiologji
FamiljaProcess / pipelineProcess / pipeline
Viti i origjinës1990s–2000s (formalized with ICH E2E and EMA PASS guidelines)Mid-20th century (formal epidemiological design codified ~1950s)
KrijuesiRegulatory and pharmacoepidemiology community (ICH, EMA, FDA frameworks)Doll & Hill (British Doctors Study, 1951); Snow (cholera, 1854)
LlojiObservational / quasi-experimental clinical study designObservational longitudinal study design
Burimi themeluesStrom, B. L. (Ed.). (2005). Pharmacoepidemiology (4th ed.). John Wiley & Sons. ISBN: 978-0470863107Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641
Emërtime të tjerarisk-adjusted post-marketing surveillance study, adjusted Phase IV trial, risk-stratified post-authorization study, PASS with risk adjustmentlongitudinal study, follow-up study, panel study, incidence study
Të lidhura36
PërmbledhjaA risk-adjusted Phase IV study is an observational or semi-experimental post-marketing study conducted after a drug or device has received regulatory approval. It uses statistical risk-adjustment techniques — such as propensity score matching, inverse probability weighting, or multivariable regression — to control for confounding by indication and baseline patient differences, thereby producing more credible safety, effectiveness, and utilization estimates than unadjusted real-world analyses.A cohort study assembles a group of individuals who share a common starting point — typically freedom from the outcome of interest — and follows them over time to observe who develops the outcome. By comparing incidence rates between exposed and unexposed subgroups, researchers can estimate relative risk and absolute risk differences. Cohort studies are the gold-standard observational design for measuring disease incidence and establishing temporal relationships between exposure and outcome.
ScholarGateSeti i të dhënave
  1. v1
  2. 2 Burimet
  3. PUBLISHED
  1. v1
  2. 2 Burimet
  3. PUBLISHED

Shko te kërkimi Shkarko diapozitivat

ScholarGateKrahasoni metodat: Risk-adjusted Phase IV study · Cohort Study. Marrë më 2026-06-18 nga https://scholargate.app/sq/compare